RxDoctor Payments Data

Gabriel Gabarain, MD

Plastic Surgery within the Head & Neck · Riverside, CANPI 1184971194

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $5,270 of the $7,518 with a category attached, or 70.1%. It is spread thinly across 19 manufacturers, the largest accounting for just 20.7%. Reporting peaked in 2022 at $2,975 and has fallen 70.6% since, to $874 in 2025.

$7,518in general payments, 2019–2025

Across 169 payments — averaging $44.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$2K
  • Stryker$2K
  • Inspire Medical Systems, Inc.$1K
  • GSK$775
  • Sanofi$476
  • Medical Device Business Services, Inc.$475
  • plus $1K from 13 others

What the payments were for

  • Travel & lodging$2,24830%
  • Food & beverage$5,27070%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,518 in reported general payments places this provider in the 85th percentile of 119 plastic surgery within the head & neck providers in California.

See all plastic surgery within the head & neck providers in California

Medicare billing

Part B allowed, 2024
$132,670
Medicare patients
212
Services billed
730

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Azelastine Hcl83$3,719
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth22$3,090
Fluticasone Propionate234$2,797
Pantoprazole Sodium173$955
Omeprazole33$807
Ipratropium Bromide11$483
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav35$297
Montelukast Sodium35$223
Methylprednisolone36$213
Mupirocin15$126
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen17$95
Levofloxacin20$74

Paid to pharmacies, not to this prescriber.

Other plastic surgery within the head & neck in Riverside

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →